Indonesia vs Malaysia: HIV-positive TB patients on ART (antiretroviral therapy)
Indonesia
54.0%
in 2024
Malaysia
39.0%
in 2024
Indonesia rank
138th
Malaysia rank
140th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Indonesia
- Malaysia
How they compare
Indonesia currently reports 54.0% against 39.0% in Malaysia, a difference of 15.0%.
That makes Indonesia's figure about 1.4 times Malaysia's.
The two have swapped places 6 times across 16 shared years of data; in 2009 it was Indonesia ahead.
Indonesia ranks 138th and Malaysia ranks 140th of 144 countries.
Across the 3 decades both report, Indonesia averaged higher in 2 and Malaysia in 1.
Head to head by decade
| Decade | Indonesia | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.0% | 10.0% | 32.0% | Indonesia |
| 2010s | 36.4% | 37.1% | 0.7% | Malaysia |
| 2020s | 39.8% | 33.2% | 6.6% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Indonesia or Malaysia?
- Indonesia, at 54.0% against 39.0% in Malaysia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Indonesia and Malaysia?
- 15.0%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Malaysia?
- 16 years are reported by both, from 2009 to 2024.
- How do Indonesia and Malaysia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Indonesia ranks 138th and Malaysia ranks 140th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.